Semax and Selank are synthetic heptapeptides developed from distinct endogenous parent molecules. While Semax targets neurotrophin expression and neuroprot
Read more Semax vs. Selank: Comparative Mechanisms, Neurochemistry, and Research Evidence
Semax is a synthetic ACTH(4-7) analog investigated for acute ischemic stroke and neurological rehabilitation. Research demonstrates that it upregulates BDN
Read more Semax in Ischemic Stroke Research: Mechanisms and Clinical Trials
Semax is a synthetic ACTH(4-10) analog that exhibits potent neuroprotective, neurotrophic, and cognitive-modulating properties across clinical and pre-clin
Read more Semax Research Guide: Mechanisms, Neurotrophic Actions, and Clinical Evidence